The role of complement in the acquired immune response
- 1 May 2000
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 100 (1) , 4-12
- https://doi.org/10.1046/j.1365-2567.2000.00009.x
Abstract
Summary: Studies over the past three decades have clearly established a central role for complement in the promotion of a humoral immune response. The primary function of complement, in this regard, is to opsonize antigen or immune complexes for uptake by complement receptor type 2 (CR2, CD21) expressed on B cells, follicular dendritic cells (FDC) and some T cells. A variety of mechanisms appear to be involved in complement‐mediated promotion of the humoral response. These include: enhancement of antigen (Ag) uptake and processing by both Ag‐specific and non‐specific B cells for presentation to specific T cells; the activation of a CD21/CD19 complex‐mediated signalling pathway in B cells, which provides a stimulus synergistic to that induced by antigen interaction with the B‐cell receptor (BCR); and promotion of the interaction between B cells and FDC, where C3d‐bearing immune complexes participate in intercellular bridging. Finally, current studies suggest that CR2 may also play a role in the determination of B‐cell tolerance towards self‐antigens and thereby hold the key to the previously observed correlation between deficiencies of the early complement components and autoimmune disease.Keywords
This publication has 110 references indexed in Scilit:
- Complement deficiency and autoimmunityCurrent Opinion in Pediatrics, 1998
- The requirement of localized, CR2‐mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cellsImmunology, 1998
- Immunization with immune complex alters the repertoire of antigen‐reactive B cells in the germinal centersEuropean Journal of Immunology, 1997
- Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer productionEuropean Journal of Immunology, 1997
- Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)Clinical and Experimental Immunology, 1995
- Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoproteinMolecular Immunology, 1995
- Covalent binding of C3b to monoclonal antibodies selectively up‐regulates heavy chain epitope recognition by T cellsEuropean Journal of Immunology, 1994
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; Inhibition of Fcγ-receptors by the covalently fixed C3 fragmentsMolecular Immunology, 1988
- Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus ErythematosusNew England Journal of Medicine, 1979